COMMUNIQUÉS West-GlobeNewswire

Zelluna ASA – Extraordinary General Meeting held on September 9, 2026
09/09/2026
Oslo, September 9, 2026: Zelluna ASA held its extraordinary general meeting today September 9, 2026. All the matters on the agenda were approved. The minutes from the meeting are enclosed and available at the company’s [...]
Medicana Uses Robot-Assisted Technology to Perform Heart Surgery Through Small Ports
09/09/2026
Medicana Health Group ’s Prof. Suat Büket, MD explains how selected bypass and heart-valve procedures can be completed without dividing the breastbone while maintaining the same surgical objective Photo: Robotic heart [...]
BayCare Generates $13 Billion in Economic Impact Annually for Florida
09/09/2026
CLEARWATER, Fla., Sept. 09, 2026 (GLOBE NEWSWIRE) -- BayCare’s commitment to serving the health care needs of the growing West Central Florida region also means positive outcomes for Florida’s economy. A new report by [...]
Zealand Pharma to participate in the Morgan Stanley 24th Annual Global Healthcare Conference
09/09/2026
Press release – No. 15 / 2026 Zealand Pharma to participate in the Morgan Stanley 24 th Annual Global Healthcare Conference Copenhagen, Denmark, September 9, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), [...]
Wellcome Leap Appoints John Young and Thomas Glanzmann to Board of Directors
09/09/2026
SAN DIEGO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Wellcome Leap (Leap), a U.S. nonprofit founded by the Wellcome Trust to accelerate breakthroughs in human health, today announced that John Young and Thomas Glanzmann have [...]
Quetzal Therapeutics Appoints Harindra R. Abeysinghe, Ph.D., as Chief Regulatory and Quality Officer
09/09/2026
CHICAGO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a biopharmaceutical company focused on developing therapies for rare diseases, including hematologic malignancies, today announced the appointment of [...]
Fast Company Names Visory Health to Its 2026 Best Workplaces for Innovators List
09/09/2026
The company’s collaborative culture and commitment to empowering employees earned the prestigious recognition ESTERO, Fla., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Visory Health , a top-three prescription discount card [...]
OSE Immunotherapeutics se félicite de l’inclusion du premier patient traité par Veloxis dans l’étude de phase 2 RENGEVITY-201 évaluant le pegrizeprument (VEL-101) dans la prévention du rejet d’organe chez les patients transplantés rénaux
09/09/2026
Nantes, le 9 septembre 2026 – 18h00 CEST – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnémo : OSE) (la « Société ») se félicite de l’annonce de son partenaire Veloxis Pharmaceuticals, Inc. relative au traitement [...]
OSE Immunotherapeutics Welcomes First Patient Dosed by Veloxis in the Phase 2 RENGEVITY-201 Trial Evaluating Pegrizeprument (VEL-101) for the Prevention of Organ Rejection in Kidney Transplant Recipients
09/09/2026
Nantes, France, September 9, 2026 – 6pm CEST – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (the “Company”) welcomes the announcement by its licensee Veloxis Pharmaceuticals, Inc. that the first patient [...]
UF Health Collaborates with R1 on AI-Powered Revenue Cycle Transformation with Phare OS
09/09/2026
The company’s R37 Innovation Lab, in a strategic alliance with leading UF academic research, rolls out AI-native capabilities across all phases of the revenue cycle, setting the standard for a technology-first RCM [...]
Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European Cities
09/09/2026
Growing Multi-City Program Continues to Increase Awareness of Proteus and Support Customer Funnel Development Ahead of Commercial Launch BRANFORD, Conn., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated ( [...]
Jushi Holdings Inc. Announces Open-Market Share Purchases by Chief Executive Officer, Chairman and Founder Jim Cacioppo
09/09/2026
BOCA RATON, Fla., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) ( OTCQX: JUSH ), a vertically integrated, multi-state cannabis operator, announced today that Chief [...]
Weight Watchers Appoints Stephen Bye as Chief Executive Officer
09/09/2026
Seasoned CEO Brings Track Record of Business Transformation, Consumer Subscription Growth and Significant Value Creation NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers [...]
Sinaptica Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
09/09/2026
CAMBRIDGE, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Sinaptica Therapeutics, a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Alzheimer’s and other [...]
IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development
09/09/2026
Renowned γδ T cell and T cell engager (TCE) expert brings two decades of drug discovery and development experience to IN8bio Appointment strengthens IN8bio’s leadership and domain expertise as they advance their novel [...]
Callio Therapeutics Appoints Zachary Hornby as Chief Executive Officer
09/09/2026
Veteran biotech executive to lead company growth as it advances multiple dual-payload ADCs through clinical development for people living with cancer Piers Ingram, PhD, Co-Founder, transitions to Senior Advisor and [...]
Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
09/09/2026
REDWOOD CITY, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a clinical stage biotechnology company focused on the design and development of innovative therapies to treat [...]
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/09/2026
BRISBANE, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today [...]
Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates
09/09/2026
SAN DIEGO and SUZHOU, China, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel [...]

Pages